This article was to show the advances being made in fibrin products. The mechanisms are the same as in the surgical product with the exception of the longer set time.

In my opinion autologous fibrin treatments are best as they use the patient own components thus lowering the risk.

Thanks for commenting.

__________________
Mr. Jan B. Wade
Blood Management Consultant
Enhance Outcomes - Control Cost
For Information Call - 360 296-1807
Email